top of page

Dr. Holly Reeve

HydRegen

We tackle limitations with using biocatalysis at an early stage in industrial R&D, where agility, speed and predictability are essential, whilst also validating our scale up strategies with industry leaders, where cost, productivity and reproducibility are critical.

Dr. Holly Reeve
bottom of page